Welcome to NewPressRelease.com a free press release service. Publishing press releases for Public Relations never been easier. Just register (it's free and it takes less then a 1 minute) then use Submit Press Release. Our services aim to help you reach journalists and to improve visibility in search engine listings, so you can get the most publicity possible.

The Japanese Pharmaceutical Market Outlook to 2014

Health and Fitness

(Free Press Release) Bharatbook.com has added this latest report The Japanese Pharmaceutical Market Outlook to 2014 to their extensive collection of market research reports. The report gives a strategic insight into the leading Anatomical Therapeutic Classification (ATC) classes, brands and pharmaceutical players in the Japanese pharmaceutical market.

The Japanese Pharmaceutical Market Outlook to 2014


       Normal 0 false false false MicrosoftInternetExplorer4 st1\:*{behavior:url(#ieooui) } /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin:0in; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Times New Roman"; mso-ansi-language:#0400; mso-fareast-language:#0400; mso-bidi-language:#0400;}

Bharatbook.com has added this latest report "The Japanese Pharmaceutical Market Outlook to 2014" to their extensive collection of market research reports. The report gives a strategic insight into the leading Anatomical Therapeutic Classification (ATC) classes, brands and pharmaceutical players in the Japanese pharmaceutical market. The top 10 brands and companies were selected from a pool of Japanese drug majors and were then rank-ordered and profiled based on 2008 revenues and market share presence in the country. RBHC0250

Features and benefits

* Understand how recent events are affecting the performance of major products, and how their marketers are confronting competitive challenges.

* Analyze the Japanese pricing & regulation environment and the epidemiological status of common indications/risk factors in the country.

* Compare the franchises of top pharmaceutical players across major indications, and understand how market share of leading companies will evolve.

* Gain up-to-date competitive intelligence across a wide-range of marketed products, market share data, sales forecasts and the competitive landscape.

* Understand which indications have the greatest potential to provide franchise growth, and how companies are attempting to exploit them.

Highlights

The Japanese pharmaceutical market registered sales growth of 17.2% from 2007 to 2008. According to Business Insights estimates, targeted therapies and antineoplastics & immunomodulating agents will have the highest growth with CAGR of 19.8% and 10.1%, respectively, over the forecast period.

The leading brands in the Japanese pharmaceutical market had a predominance of cardiovascular drugs. The top 10 products in the market constituted a very small portion of the market with only 11.4% share in 2008. Takeda’s angiotensin-II inhibitor drug Blopress led the market in 2008.

Novartis’ generic division Sandoz became the first company to launch a therapeutic biosimilar (Somatropin BS) in Japan. Initially approved in June 2009 for the treatment of growth hormone deficiency in children, growth disturbance associated with Turner's syndrome and chronic renal insufficiency.

Your key questions answered

* Which indications represent the best growth oportunities in the Japanese pharmaceutical market over the period 2008–14?

* Which companies (both multinational and domestic) will become the key players in the Japanese pharma market over the period 2008–14?

* Which products will be the future growth drivers for the Japanese pharmaceutical market and conversely which will be affected by generic erosion?

* How will the the competitive landscape of various therapeutic areas evolve in the market by 2014?

* How will healthcare reforms impact the market in Japan?


For more information kindly visit: http://www.bharatbook.com/detail.asp?id=130208&rt=The-Japanese-Pharmaceutical-Market-Outlook-to-2014.html

Related Reports:

Japanese Market for Interventional Cardiology 2010
http://www.bharatbook.com/detail.asp?id=135243&rt=Japanese-Market-for-Interventional-Cardiology-2010.html

Stakeholder Opinions: Tropical Diseases - Dengue, Japanese encephalitis and West Nile virus - Increasing attention for neglected diseases
http://www.bharatbook.com/detail.asp?id=173660&rt=Stakeholder-Opinions-Tropical-Diseases-Dengue-Japanese-encephalitis-and-West-Nile-virus-Increasing-attention-for-neglected-diseases.html

Or

Contact us at :

Bharat Book Bureau
Tel: +91 22 27578668
Fax: +91 22 27579131
Email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Website: www.bharatbook.com
Follow us on twitter: http://twitter.com/3bbharatbook
Please visit our blog at http://bharatresearch.wordpress.com




The Japanese Pharmaceutical Market Outlook to 2014

Source: Press Release

---------------------------

Disclaimer

If you have any questions regarding information in this press release, please contact the person listed as the Author or use the contact informations published in the press release. Please do not attempt to contact NewPressRelease.com. We are unable to assist you with any information regarding this release. NewPressRelease.com disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.

Related Items

All press release information on this site, including free press releases, is solely based on what our users submit. NewPressRelease.com disclaims that any right and responsibility for the information goes to the user who submit the press release. Some press release may be confusing without additional explanation. You should contact the provider with any questions about the information presented. In case some press release damages your benefits or violate your rights in any way, please contact us and we'll remove it immediately.


Copyright © 2008 - 2018 Free Press Release by NewPressRelease.com